Lindsay Lief, M.D.

Samuel Jaemin Chung, M.D. is a highly skilled pulmonary disease medicine specialist providing world-class care at NewYork-Presbyterian Hospital. With a focus on phenotyping patients with pulmonary hypertension and right ventricular dysfunction, Dr. Chung conducts research using multiomic analysis to identify metabolomic markers of early right ventricular dysfunction. He is dedicated to delivering exemplary and individualized clinical care while making groundbreaking biomedical discoveries. Weill Cornell Medicine, where Dr. Chung practices, is committed to putting patients first and is renowned for its expertise in healthcare. As a leading academic medical center, Weill Cornell Medicine is dedicated to advancing patient care through innovative research, education, and clinical trials. With a transparent environment and a team of highly skilled physicians and scientists, Weill Cornell Medicine strives to provide exceptional care, discover new medical breakthroughs, and educate the next generation of healthcare professionals.Generated from the website

Dr. Niederman's career is dedicated to the care of patients with complex lung diseases, with a particular focus on respiratory tract infections including pneumonia, Chronic Obstructive Pulmonary Disease (COPD), sepsis and respiratory failure. He is an expert in the management of patients with pneumonia, has written national and international pneumonia guidelines, and researches new therapies for pneumonia that can optimize treatment of patients infected with antibiotic-resistant pathogens.Dr. Niederman has published over 350 articles and book chapters related to these efforts and is active in national pulmonary and critical organizations. He received the Laureate Award from the American College of Physicians. He is currently on the editorial boards of CHEST, Critical Care Medicine, Critical Care, and Intensive Care Medicine. Click here to listen to Dr. Niederman speak about cardiac complications in community-acquired pneumonia.

Dr. Podolanczuk is a nationally and internationally recognized expert in interstitial lung disease. She received her undergraduate degree in Neuroscience from Brown University. She earned her MD from NYU School of Medicine. She completed residency in Internal Medicine and fellowship in Pulmonary and Critical Care Medicine at Columbia University. She received additional training in advanced pulmonary diseases at Columbia University. She also earned a Masters of Science in Patient-Oriented Research from Columbia’s Mailman School of Public Health, with a focus on epidemiology and biostatistics.Dr. Podolanczuk is an NIH-funded investigator studying novel risk factors for pulmonary fibrosis in humans. Her research program focuses on understanding early or subclinical interstitial lung disease, characterizing imaging and blood biomarkers of pulmonary fibrosis, the role of environmental exposures, and the connection between cardiovascular disease and pulmonary fibrosis. She is also a site investigator for several multi-center clinical trials of new therapies for pulmonary fibrosis.